Bridgene Biosciences, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Holding
- Established
- 2018-01-01
- Employees
- 11
- Market Cap
- -
- Website
- http://www.bridgenebio.com
Clinical Trials
1
Active:0
Completed:0
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (100.0%)A Study of BGC515 Capsules in Subjects With Advanced Solid Tumors
Phase 1
Recruiting
- Conditions
- MesotheliomaEpithelioid Hemangioendothelioma(EHE)Solid Tumor
- Interventions
- First Posted Date
- 2024-06-11
- Last Posted Date
- 2024-08-09
- Lead Sponsor
- BridGene Biosciences Inc.
- Target Recruit Count
- 103
- Registration Number
- NCT06452160
- Locations
- 🇺🇸
MD Anderson Cancer Center, Houston, Texas, United States
News
No news found